NCT03120273View on ClinicalTrials.gov

A Clinical Trial to Evaluate the Safety and Tolerability of Dexlansoprazole Injection in Healthy Chinese Adults（Part 2）

PHASE1UnknownINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

September 30, 2017

Conditions
Effect of DrugsSafety Issues
Interventions
DRUG

Dexlansoprazole Injection

15mg q12h,30mg q12h,15mg qd,30mg qd for 5 days

DRUG

Lansoprazole Injection

30 mg q12h for 5 days.

Trial Locations (1)

310003

RECRUITING

First affiliated hospital of Zhejiang University, Hangzhou

Sponsors
All Listed Sponsors
collaborator

Jiangsu Aosaikang Pharmaceutical Co., Ltd.

INDUSTRY

lead

First Affiliated Hospital of Zhejiang University

OTHER